User menu

Predicting febrile neutropenic patients at low risk using the MASCC score: Does bacteremia matter?

Bibliographic reference Paesmans, Marianne ; Klastersky, Jean ; Maertens, Johan ; Georgala, Aspasia ; Muanza, Frédérique ; et. al. Predicting febrile neutropenic patients at low risk using the MASCC score: Does bacteremia matter?. In: Supportive Care in Cancer, Vol. 19, no. 7, p. 1001-1008 (2011)
Permanent URL
  1. Klastersky J., Ameye L., Maertens J., Georgala A., Muanza F., Aoun M., Ferrant A., Rapoport B., Rolston K., Paesmans M., Bacteraemia in febrile neutropenic cancer patients, 10.1016/j.ijantimicag.2007.06.012
  2. Klastersky J, Zinner SH, Calandra T et al (1988) Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials. Eur J Cancer Clin Oncol 24(suppl 1):S35–S45
  3. Viscoli C., Bruzzi P., Castagnola E., Boni L., Calandra T., Gaya H., Meunier F., Feld R., Zinner S., Klastersky J., Glauser M., Factors associated with bacteraemia in febrile, granulocytopenic cancer patients, 10.1016/0959-8049(94)90412-x
  4. Nørgaard M., Larsson H., Pedersen G., Schønheyder H.C., Sørensen H.T., Risk of bacteraemia and mortality in patients with haematological malignancies, 10.1111/j.1469-0691.2005.01298.x
  5. Talcott JA, Siegel RD, Finberg R, Goldman L (1992) Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol 10:316–322
  6. Klastersky J, Paesmans M, Rubenstein EB et al (2000) The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18:3038–3051
  7. Uys A, Rapoport BL, Anderson R (2004) Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score. Support Care Cancer 12:555–560
  8. Klastersky Jean, Paesmans Marianne, Georgala Aspasia, Muanza Frédérique, Plehiers Barbara, Dubreucq Laurent, Lalami Yassine, Aoun Michel, Barette Martine, Outpatient Oral Antibiotics for Febrile Neutropenic Cancer Patients Using a Score Predictive for Complications, 10.1200/jco.2005.03.9909
  9. Hughes Walter T., Armstrong Donald, Bodey Gerald P., Bow Eric J., Brown Arthur E., Calandra Thierry, Feld Ronald, Pizzo Philip A., Rolston Kenneth V. I., Shenep Jerry L., Young Lowell S., 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer, 10.1086/339215
  10. DeLong Elizabeth R., DeLong David M., Clarke-Pearson Daniel L., Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach, 10.2307/2531595
  11. Kern W. V., Heiss M., Steinbach G., Prediction of Gram-Negative Bacteremia in Patients with Cancer and Febrile Neutropenia by Means of Interleukin-8 Levels in Serum: Targeting Empirical Monotherapy versus Combination Therapy, 10.1086/319207
  12. Massaro Karin SR, Costa Silvia F, Leone Claudio, Chamone Dalton AF, Procalcitonin (PCT) and C-reactive Protein (CRP) as severe systemic infection markers in febrile neutropenic adults, 10.1186/1471-2334-7-137
  13. UYS A., RAPOPORT B.L., FICKL H., MEYER P.W.A., ANDERSON R., Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1β, -6, -8 and -10, 10.1111/j.1365-2354.2007.00780.x
  14. Elting Linda S., Rubenstein Edward B., Rolston Kenneth V. I., Bodey Gerald P., Outcomes of Bacteremia in Patients with Cancer and Neutropenia: Observations from Two Decades of Epidemiological and Clinical Trials, 10.1086/514550
  15. Freifeld Alison, Marchigiani Donna, Walsh Thomas, Chanock Stephen, Lewis Linda, Hiemenz John, Hiemenz Sharon, Hicks Jeanne E., Gill Vee, Steinberg Seth M., Pizzo Philip A., A Double-Blind Comparison of Empirical Oral and Intravenous Antibiotic Therapy for Low-Risk Febrile Patients with Neutropenia during Cancer Chemotherapy, 10.1056/nejm199907293410501
  16. Kern Winfried V., Cometta Alain, de Bock Robrecht, Langenaeken John, Paesmans Marianne, Zanetti Giorgio, Calandra Thierry, Glauser Michel P., Crokaert Françoise, Klastersky Jean, Skoutelis Athanasios, Bassaris Harry, Zinner Stephen H., Viscoli Claudio, Engelhard Dan, Padmos Andrew, Gaya Harold, Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer Chemotherapy, 10.1056/nejm199907293410502